Targeting angiogenesis has remained one of the important aspects in disease biology in
general and cancer in particular. Currently (June 2023), over 593 clinical trials have been …

Diabetic nephropathy (DN) is an important public health concern of increasing proportions
and the leading cause of end-stage renal disease (ESRD) in diabetic patients. It is one of the …

Although platelet-rich plasma (PRP) is used as a source of growth factors in regenerative
medicine, its effectiveness remains controversial, partially due to the absence of PRP …

Background Several studies have linked vascular endothelial growth factors (VEGFs) with
metabolic syndrome or its components. However, there has been no systematic appraisal of …

Angiogenesis has been shown to be a potential therapeutic target for early stages of
diabetic nephropathy in a number of animal experiments. Vascular endothelial growth factor …

We aimed to explore the active ingredients and molecular mechanism of Tripterygium
wilfordii (TW) in the treatment of diabetic nephropathy (DN) through network pharmacology …

Accumulating evidence suggests that pathologic interactions between the heart and the
kidney can contribute to the progressive dysfunction of both organs. Recently, there has …

Diabetes and the associated complications are becoming a serious global threat and an
increasing burden to human health and the healthcare systems. Diabetic nephropathy (DN) …

Background/Aims: High glucose-induced oxidative stress and inflammatory responses play
an important role in painful diabetic neuropathy by activating the TLR4/NFκB signal …

Objective: To investigate the effects of liraglutide combined with insulin on oxidative stress
and expression levels of serum monocyte chemoattractant protein-1 (MCP-1) and nuclear …